GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Integral Diagnostics Ltd (ASX:IDX) » Definitions » Forward PE Ratio

Integral Diagnostics (ASX:IDX) Forward PE Ratio : 19.92 (As of May. 12, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Integral Diagnostics Forward PE Ratio?

Integral Diagnostics's Forward PE Ratio for today is 19.92.

Integral Diagnostics's PE Ratio without NRI for today is 0.00.

Integral Diagnostics's PE Ratio for today is 0.00.


Integral Diagnostics Forward PE Ratio Historical Data

The historical data trend for Integral Diagnostics's Forward PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Integral Diagnostics Forward PE Ratio Chart

Integral Diagnostics Annual Data
Trend 2018-12 2019-12 2020-12 2021-12 2022-12 2023-12 2024-05
Forward PE Ratio
14.20 21.69 21.69 25.32 30.30 24.45 19.92

Integral Diagnostics Semi-Annual Data
2018-03 2018-06 2018-09 2018-12 2019-03 2019-06 2019-09 2019-12 2020-03 2020-06 2020-09 2020-12 2021-03 2021-06 2021-09 2021-12 2022-03 2022-06 2022-09 2022-12 2023-03 2023-06 2023-09 2023-12 2024-03
Forward PE Ratio 16.08 16.78 14.47 14.20 13.53 17.18 18.18 21.69 10.49 22.52 20.58 21.69 22.37 24.88 24.15 25.32 18.62 15.11 24.81 30.30 22.62 24.10 22.94 24.45 18.15

Competitive Comparison of Integral Diagnostics's Forward PE Ratio

For the Diagnostics & Research subindustry, Integral Diagnostics's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Integral Diagnostics's Forward PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Integral Diagnostics's Forward PE Ratio distribution charts can be found below:

* The bar in red indicates where Integral Diagnostics's Forward PE Ratio falls into.



Integral Diagnostics Forward PE Ratio Calculation

It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.


Integral Diagnostics  (ASX:IDX) Forward PE Ratio Explanation

The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.

Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .


Integral Diagnostics Forward PE Ratio Related Terms

Thank you for viewing the detailed overview of Integral Diagnostics's Forward PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Integral Diagnostics (ASX:IDX) Business Description

Traded in Other Exchanges
Address
45 William Street, Suite 9.02, Level 9, Melbourne, VIC, AUS, 3000
Integral Diagnostics is Australia's fourth-largest diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.

Integral Diagnostics (ASX:IDX) Headlines